Abstract
Translocations affecting the chromosomal locus 11q23 are hallmarks of infant leukemias. These events disrupt the MLL gene (also ALL-1 or HRX) and fuse the MLL amino terminus in frame with a variety of unrelated proteins. The ENL gene on 19p13.1 is a recurrent fusion partner of MLL. Whereas potential functions have been suggested for isolated domains of either MLL or ENL no experimental data exist for the biological properties of the complete chimeric MLL-ENL protein. We show here that the fusion of MLL with ENL creates a novel molecule that is a potent general transcriptional transactivator in transient reporter gene assays. MLL-ENL strongly transactivated several unrelated promoters including the promoter of Hoxa7 a potential target gene for the unaltered MLL protein. This transactivation capability was cell type specific and it was critically dependent on the contributions of the methyltransferase-homology (MT) region of MLL in combination with the C-terminus of ENL. Squelching experiments and gel retardation studies identified the ENL C-terminus as a binding partner for an unknown factor and the MLL MT region as a unique general DNA binding motif. The potential implications of these findings for the leukemogenesis by MLL-ENL are discussed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schreiner, S., García-Cuéllar, M., Fey, G. et al. The leukemogenic fusion of MLL with ENL creates a novel transcriptional transactivator. Leukemia 13, 1525–1533 (1999). https://doi.org/10.1038/sj.leu.2401534
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401534
Keywords
This article is cited by
-
Regulation of MEIS1 by distal enhancer elements in acute leukemia
Leukemia (2014)
-
Both SEPT2 and MLL are down-regulated in MLL-SEPT2therapy-related myeloid neoplasia
BMC Cancer (2009)
-
Alterations of the CxxC domain preclude oncogenic activation of mixed-lineage leukemia 2
Oncogene (2009)
-
MYST opportunities for growth control: yeast genes illuminate human cancer gene functions
Oncogene (2007)
-
Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers
Nature Reviews Genetics (2006)